Lisa F. Stinson
Matthew S. Payne
Jeffrey A. Keelan- Division of Obstetrics and Gynaecology, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA, Australia
Numerous studies suggest that infants delivered by cesarean section are at a greater risk of non-communicable diseases than their vaginal counterparts. In particular, epidemiological studies have linked Cesarean delivery with increased rates of asthma, allergies, autoimmune disorders, and obesity. Mode of delivery has also been associated with differences in the infant microbiome. It has been suggested that these differences are attributable to the “bacterial baptism” of vaginal birth, which is bypassed in cesarean deliveries, and that the abnormal establishment of the early-life microbiome is the mediator of later-life adverse outcomes observed in cesarean delivered infants. This has led to the increasingly popular practice of “vaginal seeding”: the iatrogenic transfer of vaginal microbiota to the neonate to promote establishment of a “normal” infant microbiome. In this review, we summarize and critically appraise the current evidence for a causal association between Cesarean delivery and neonatal dysbiosis. We suggest that, while Cesarean delivery is certainly associated with alterations in the infant microbiome, the lack of exposure to vaginal microbiota is unlikely to be a major contributing factor. Instead, it is likely that indication for Cesarean delivery, intrapartum antibiotic administration, absence of labor, differences in breastfeeding behaviors, maternal obesity, and gestational age are major drivers of the Cesarean delivery microbial phenotype. We, therefore, call into question the rationale for “vaginal seeding” and support calls for the halting of this practice until robust evidence of need, efficacy, and safety is available.
Background
Cesarean section (CS) delivery can be a life-saving procedure. However, globally, rates of elective CS delivery are increasing. In Organization for Economic Co-operation and Development countries, more than a quarter of infants are now born by CS (1). The increasing popularity of elective CS delivery has coincided with a rising prevalence in non-communicable diseases, prompting investigations into a possible causal link between the two.
Epidemiological studies have identified CS delivery as a risk factor for neonatal infections. In the US, 64–82% of reported cases of neonatal methicillin-resistant Staphylococcus aureus skin infections occur in Cesarean section delivered (CSD) infants (2). CS delivery has also been recognized as a risk factor for necrotizing enterocolitis in preterm infants (3). Epidemiological studies also suggest that CSD infants experience an increased risk of the onset of several chronic immune diseases later in life: a large body of research has linked CS delivery with childhood asthma (4–6), atopic disease (7–9), allergies (9, 10), obesity (11), type 1 diabetes mellitus (12), and inflammatory bowel disease (5, 13). More recently, CS delivery has been associated with impaired cognitive abilities in school aged children (14). It has been widely promulgated that such associations are caused by perturbations in the early-life microbiome as a consequence of lack of exposure to vaginal microbiota at delivery. However, such studies are purely associative and are unable to determine causation or mechanism. There is, therefore, an urgent need to assess whether these associations are causal or reflective of confounding factors, and to determine the extent to which the establishment of the early-life microbiome is involved. In particular, it is necessary to assess whether such studies support the rationale for “vaginal seeding” (the transfer of vaginal fluid, and the microbes contained therein, to the neonate).
The infant microbiota is foundational for later-life health (15). The early-life gut microbiota interact—primarily via the production and release of microbial metabolites and degradation products—with the developing immune system and contribute to immune programming and sensitization (16, 17). Aberrations in the establishment of this ecosystem in infants and children underpin the risk for immune-mediated diseases, such as asthma (18–21), allergies (22–25), and inflammatory bowel disease (26, 27), as well as metabolic conditions, such as obesity (28) and a variety of behavioral, cognitive, and mental health conditions (29). It has been suggested that a decline in exposure to microbes during prenatal and early postnatal life has contributed to the increase in the prevalence of non-communicable diseases in developed nations—the “hygiene hypothesis” (30). Thus, any effect of CS delivery on the developing infant microbiome might confer risks for later-life morbidity.
In this review, we present a critical evaluation of the current evidence for a causal link between CS delivery and neonatal dysbiosis. For the purposes of this review, we use the term “neonate” to refer to infants aged up to 3 days, and the term “infant” to refer to infants aged 4 days to 1 year.
CS Delivery: Effects on the Neonatal Microbiome
It is commonly assumed that passage through the birth canal seeds the neonatal microbiome with vaginal bacteria. If this is so, the effect of CS delivery would be expected to be most apparent in the first days following birth, with VD neonates exhibiting higher rates of colonization with predominant vaginal bacteria, particularly specific Lactobacillus spp., such as L. crispatus, L. gasseri, L. jensenii, and L. iners. Such differences should be most obvious in the neonatal skin and oral microbiomes, though some effect on the gut microbiome may also be apparent. As time progresses, the effect of delivery mode would be expected to become less obvious, as other microbiome-driving factors, such as breastfeeding and environmental exposures come in to play and each microbial niche acquires its own unique microbiota.
Previous studies have reported that differences in the gut microbiome between CSD and VD neonates do not develop until several days after birth (31). Wampach et al. tracked the colonization and succession of bacteria, archaea, and microeukaryotes in the feces of infants born from vaginal (n = 8) or CS delivery (n = 7) (31). They found that differences in the gut microbiomes of CSD and VD neonates were not apparent until day 5 of life. After this time point, they reported depletion of sequences affiliated with the phylum Bacteroidetes in CSD infants, resulting in a significant increase in the Firmicutes/Bacteroidetes ratio between days 5 and 150 compared to VD infants. Considering the large number of genera and species contained within these two phyla and associated differences in 16S rRNA gene copy number, however, the biological relevance of this finding is difficult to state.
Numerous studies describing the bacterial microbiota of first pass meconium (the first fecal material, passed shortly after birth) support the notion that CSD and VD neonates do not differ in their bacterial microbiomes in the first few days following birth. Hu et al.’s study of 23 neonates (10 of which were delivered by CS), reported no significant differences in the meconium microbiota of full-term VD and CSD neonates (32). Similarly, Mshvildadze et al. reported no significant differences in the meconium microbiota of pre-term (23–32 weeks of gestational age) VD and CSD neonates (CSD n = 13, VD n = 10) (33). Dong et al. compared the vaginal and placental microbiomes of mothers, and meconium microbiomes of neonates from one Cesarean delivery and one vaginal delivery (34). There were no significant differences in bacterial communities in the meconium of the two neonates, which were similar to the mother’s placenta regardless of the method of delivery. However, given that both meconium and the placenta contain a very low biomass microbiome, this similarity may in fact be a reflection of the “kitome” [reagent-derived contaminating bacterial deoxyribonucleic acid (DNA)] (35, 36). In a more recent and much larger study, Chu et al. compared the microbial composition of 102 VD and 52 CSD neonates at birth across multiple body sites (37). Although some minor differences in the oral, nares, and skin microbial communities were observed, no differences were detected in the community structure or function of the meconium microbiome.
On the other hand, there are studies that report data to the contrary. In their investigation of the effect of gestational age on the neonatal microbiome, Ardissone et al. found that delivery mode had a strong effect on meconium microbiome structure (38). In particular, they identified four genera that were associated with mode of delivery: Leuconostoc spp., Negavicoccus spp., Vagococcus spp., and Butyrivibrio spp. Each of these genera were found to have a significantly greater relative abundance in CSD neonates (p < 0.05). Neonates are susceptible to Leuconostoc bacteremia (39). Of the other three genera noted, Vagococcus have been identified in wounds and infected oral habitats, but none are biologically relevant in either the neonatal or the adult human gut (40, 41). Thus their recovery might reflect contamination or incorrect OTU assignment. Importantly, no differences in relative abundances of vaginal bacteria were reported between groups. In their investigation into the meconium microbiome of Chinese neonates, Shi et al. found that delivery mode was the most significant contributing factor to the composition of the neonatal microbiome (42). They found that 16S rRNA gene amplicons generated from meconium DNA of VD infants (n = 8) harbored more sequences associated with Actinobacteria, Gammaproteobacteria, and Betaproteobacteria, while the meconium of CSD infants (n = 10) contained more sequences associated with Deinococcus, Alphaproteobacteria, and Bacilli. The authors also went on to demonstrate differences in predicted metabolic pathways, although given that their study could only detect bacterial DNA, not living bacteria per se, such metabolomic differences are merely speculative.
An older study by Biasucci et al. used targeted polymerase chain reaction (PCR) coupled with gradient gel electrophoresis to identify differences in colonization of selected Bifidobacterium spp., Ruminococcus spp., and Bacteroides spp. in VD (n = 23) and CSD (n = 23) neonates at day 3 of life (43). They found that Bifidobacterium spp. and Bacteroides spp. were detected in 56.5%, and 8.7% of VD infants, respectively, but were absent in CSD infants.
Dominguez-Bello et al. compared several body site microbiomes from VD (n = 4) and CSD (n = 6) neonates within an hour of delivery (44). The very small sample size and considerable variability in maternal vaginal microbiome are a significant limitation in this study. Nevertheless, they found that the microbiome of these neonates was homogenous across body sites, regardless of delivery mode. Given the likely importance of amniotic fluid in pre-natal microbiome seeding (45), this finding is not surprising. Unfortunately, the authors did not investigate placental or amniotic fluid microbiomes from these mothers, as these may have been the true source of the neonatal microbiome. The authors further reported that VD neonates harbored microbiomes most similar in composition to their mother’s vaginal microbiome, while CSD neonates harbored microbiomes most similar in composition to their mother’s skin. Given that neonates were swabbed within seconds of delivery, and thus it would be coated with vaginal fluids, this result is hardly surprising. This does not necessarily demonstrate colonization, however. It would have been far more informative if these authors sampled at a later time point or followed the colonization patterns of these neonates in the first few days following delivery to confirm true colonization.
Given recent evidence that microbiome colonization begins in utero (45, 46), the “bacterial baptism” of vaginal birth might not be as important to microbiome establishment as previously assumed. In fact, Martin et al. in a small study of five CSD and five VD neonates, demonstrated that the majority of VD infants do not acquire their mother’s vaginal lactobacilli through vertical transmission, and that Lactobacillus populations do not differ in the infant gut according to mode of delivery (47). Conversely, Nagpal et al. reported a lower detection rate of lactobacilli in the intestinal tracts of CSD neonates than in VD neonates using targeted real-time qualitative polymerase chain reaction (RT-qPCR) (48). Although this study also suffered from low numbers of CSD neonates (n = 17) compared to VD neonates (n = 134), its use of RNA-based methods is a strength as detection should be indicative of live bacterial cells. In a more recent study by Sakwinska et al., minimal overlap between maternal vaginal microbiota and neonatal fecal and nasal microbiota was reported at 3 days of life, regardless of delivery mode (VD n = 34, CSD n = 8) (49). The authors concluded that the transfer of maternal vaginal microbes do not play a major role in seeding neonatal microbiota.
Interestingly, very few studies have explored the relationship between the vaginal microbiome and the neonatal gut microbiome at the species- or strain-level. This is critical, as the bacterial baptism hypothesis would predict that the infant gut would be transiently colonized with the common vaginal lactobacilli (L. crispatus, L. gasseri, L. iners, and L. jensenii) and other vaginal commensals (e.g., G. vaginalis, A. vaginae), as opposed to other species of lactobacilli which are common in the adult gut. In particular, merely reporting on Lactobacillus levels fails to provide suitable resolution to assess the evidence for vertical transmission. In the aforementioned study by Nagpal et al., the absolute abundance of lactobacilli was lower in CSD vs. VD neonates; however, of the common vaginal species, only L. gasseri was detected in the neonates (CSD vs. VD: 6 vs. 31%), the other five species being typical gut colonizers but not found in vaginal microbiota.
While the majority of evidence suggests that delivery mode does not shape the microbiome in the first days of life, most of the studies described here involved small numbers of participants and differed substantially in the methodologies used to generate microbial profiles from samples (Table 1). Of particular importance, numerous studies did not appropriately control for contaminating reagent-derived bacterial DNA (“kitome”) that has now been shown to be ubiquitous in DNA extraction and molecular biology reagents (35). Further, appropriately controlled studies enlisting large cohorts are required to assess whether CS delivery truly disturbs the neonatal microbiome from the time of birth.
Table 1. Summary of the methodological approaches used by studies that have compared infant microbiota profiles between cesarean section (CS) and vaginal deliveries.
CS Delivery: Effects on the Infant Microbiome
Although most studies report no differences in the microbiome of VD and CSD neonates in the first days of life, evidence is compelling that differences begin to develop shortly thereafter and persist for weeks or months (Table 1).
Bäckhed and colleagues sampled the gut microbiota of 98 infants, 15 of which were delivered by CS, at 4 days, 4 months, and 1-year post-delivery (51). Although a high rate of mother-to-infant transmission of bacteria was observed, regardless of mode of delivery, this transmission was partially compromised in infants born by CS. Infants born vaginally were enriched for Bacteroides spp. across all time points and Parabacteroides spp. at 4 days and 4 months. CSD infants harbored higher relative levels of Clostridium spp. at 4 months and 1 year. Apart from these trends, the infant gut appeared to be highly dynamic throughout the first year of life.
Similar findings were reported by Penders et al. in their broad study of over 1,000 infants at 1 month of age (52). The authors observed significantly lower levels of Bacteroides spp. in CSD infants, and also found that CSD infants were more often colonized by Clostridium difficile. The biological significance of this observation is currently unclear, although it could be interpreted to be precursor of dysbiosis. Azad et al. further corroborated these finding, reporting significantly lower levels of Bacteroides spp. in CSD infants at 4 months of age (50). This study additionally identified a decrease in Escherichia–Shigella spp. in CSD infants.
Sakwinska et al. investigated the nasal and stool microbiomes of infants born vaginally (n = 34) and by CS (n = 8) at 3 days and 3 weeks of life, and compared their composition to maternal vaginal, skin, and rectal samples (49). They reported that the stool of CSD infants at week 3 was more similar to the maternal skin than that of VD infants. In their study, only VD, exclusively breastfed infants had gut microbiota dominated by Bifidobacteria spp. (which is found abundantly in breast milk and the infant gut and is believed to confer health benefits to the host).
There has been one recent study that challenged our current understanding of the CS delivery microbiome. Chu and colleagues prospectively recruited 81 mother-infant pairs (37). They reported that, after adjusting for confounders, mode of delivery had no impact on microbial community structure or function over multiple body sites (skin, oral, nares, stool) at 6 weeks of age.
In general, initial differences between VD and CSD infants’ microbiomes appear to resolve after solid foods are introduced. In Wampach et al.’s study, which expanded our current understanding of the infant microbiome into the kingdoms of archaebacteria and fungi, differences between CSD and VD infants became less pronounced after day 150 (31). The authors’ suggested that this change was driven by the introduction of solid foods. This observation is supported by several other studies which have found that introduction of solid food sparks a rapid change in the infant gut microbiome toward a more mature gut microbiome, minimizing any initial differences associated with mode of delivery (53, 54). A systematic review of seven studies concluded that there was a significant difference in the microbiota of CSD infants up until 3 months of age, but that this difference disappears after 6 months (55). Reduced levels of Bacteroides spp. in CSD infants may persist up to 4 weeks post-weaning (53).
Despite this post-weaning convergence, a transient difference in the infant gut microbiome early in life may nevertheless be biologically significant. The early-life gut microbiome plays a critical role in the development of the immune system, which impacts upon neurodevelopment (56, 57) and risk of later-life metabolic and immune-mediated diseases (15, 58, 59). Thus, it is vital to clarify the true impact of mode of delivery on the early-life microbiome. In particular, when considering potential treatment and management strategies, there is a need to elucidate whether differences seen in CSD infants are due to lack of passage through the birth canal or due to other factors associated with CS delivery.
Confounding Factors
There are numerous maternal and medical factors that confound the interpretation of studies of the microbiome and health outcomes of CSD infants. Here, we will describe the major confounding factors in such studies.
Antibiotics
Antibiotics are powerful disrupters of the developing gut microbiome. Depending on the type, dose, duration, and timing of administration (60), antibiotics can have profound effects on the development of the neonatal and/or infant microbiome. All mothers delivering by CS are administered intrapartum antibiotic prophylaxis (IAP), as is routine for any type of surgery. In some countries, IAP is administered after the cord is clamped, minimizing direct antibiotic exposure of the neonate. In others, antibiotics are given prior to commencement of surgery. For those antibiotics which cross the placenta, IAP will likely have a devastating effect on the neonate’s microbiota, although it should be born in mind that the microbial DNA will remain unaltered even if the bacteria are dead. Hence, microbiome studies may fail to appropriately recognize the effects of antibiotic exposure within the first day or so of life. Mothers delivering vaginally are not routinely administered antibiotics, with the notable exception of those who are vaginally colonized with Group B Streptococcus (GBS). Overall, rates of intrapartum antibiotic use are low in vaginally delivering mothers (61).
The effects of IAP on the neonatal gut microbiome are well-described (62–67). In particular, maternal IAP has been associated with decreased bacterial diversity in the neonatal gut, as well as a decrease in the relative abundance of Actinobacteria, Bacteroidetes, Bifidobacteria spp., Bacteroides spp., Parabacteroides spp., Atopobium spp., and Lactobacillus spp., and an increase in the relative abundance of Proteobacteria, Firmicutes, Enterobacteriaceae, Enterococcus spp., and Clostridium spp. These perturbations to the neonatal gut microbiome directly overlap with those observed in CSD infants (Table 2). Importantly, these perturbations are accompanied by a delay in the production of immunomodulatory short chain fatty acids (62).
Table 2. Genera of bacteria reported to be differentially abundant in [Bäckhed et al. (51), Sakwinska et al. (49), Penders et al. (52), Tun et al. (68), and Azad et al. (50)] cesarean section delivered (CSD) infants compared to vaginally delivered (VD) infants across five studies.
Perinatal antibiotic use has also been associated with increased risk of developing numerous morbidities (69), including asthma (70–73), allergies (74, 75), and obesity (76). It is vital to consider antibiotic use, in particular the specific types of antibiotics used and the timing of administration, when comparing the microbiome composition and health outcomes of CSD and VD infants, as differences in these infants may be directly attributable to differences in antibiotic exposure (Table 2).
Labor
The absence of labor in mothers delivering by elective CS creates a completely different biochemical landscape in the maternal body. Specifically, labor causes changes in levels of endocrine, inflammatory, and contractile factors. These changes might influence the maternal microbiome or the establishment of the neonatal microbiome. Additionally, labor is often accompanied by rupture of the fetal membranes, exposing the fetus to maternal vaginal bacteria. Accordingly, previous studies have demonstrated a difference in the neonatal microbiome of women delivering by elective CS (no labor) compared to those delivering by emergency CS (labor) (50).
Both maternal and fetal cytokines influence the developing fetal immune system. Malamitsi-Puchner et al. investigated cytokine concentrations in maternal, fetal, and neonatal blood after vaginal delivery (labor) and elective Cesarean delivery (no labor) (77). They found that vaginal delivery was associated with an increase in circulating cytokines up to 4 days post-partum, probably due to the consequences of labor, which is known to be pro-inflammatory and did not occur in the elective CS group.
Differences in levels of inflammatory and immune-mediating cytokines in CSD infants (due to absence of labor) may account for some of the observed differences in neonatal microbiome colonization and health outcomes. This possibility is supported by a number of studies showing that elective Cesarean delivery, but not emergency Cesarean delivery (where often the labor process has commenced), is associated with an increased risk of asthma (78), celiac disease (79), and psychosis (80). Interestingly, while fecal bacterial richness and diversity are lower among infants born by elective Cesarean delivery compared to those born vaginally, they are also higher in infants born by emergency Cesarean delivery compared to those born vaginally (50). This phenomenon remains to be explained.
Breastfeeding
Breast milk contains a number of important nutritional components, as well as bacteria, which have repeatedly been shown to markedly influence the infant gut microbiome (52, 63, 81–86); this, in turn, modifies host gene expression and immune development via the production of bacterial metabolites and systemic exposure to bacterial products (84–86). Source tracking studies have shown that 27% of an infant’s gut microbiota is vertically derived from its mother’s breast milk, while an additional 10% is sourced from the skin around the areola (87). Additionally, breast milk is rich in prebiotics, such as human milk oligosaccharides, which are metabolized by certain members of the gut microbiota and modify the composition of the infant gut microbiome and metabolome (88).
Cesarean section deliveries are associated with increased risk of a range of sub-optimal breast feeding parameters. These include a delay in breast feeding (89), a shortened duration of breastfeeding (90), sub-optimal breastfeeding behavior (89), and a reduced volume of breast milk consumption in the first 5 days of life (91). Given the microbial and immune modulatory properties of human breast milk, it is highly likely that differences in feeding practices between CSD and VD infants might account for some of the microbial and epidemiological differences observed in these groups. This phenomenon would also explain, in part, why differences in infant gut microbiome diminish with weaning.
Maternal Obesity
Maternal obesity is a known risk factor for Cesarean delivery in both developed and developing countries; the OR for obese women having a CS delivery compared with women of normal weight is 2.01–2.36 (68, 92–97). High maternal BMI is associated with an increased risk for failed labor, which in turn increases labor duration and ultimately leads to CS delivery (68, 92, 98).
Obesity and high-fat diets have repeatedly been correlated with aberrations to the gut microbiome in humans (99–102). Maternal obesity alters the maternal gut microbiome during pregnancy (103, 104), and the milk microbiome during lactation (105, 106), both of which are likely to influence both pre- and post-natal microbiome colonization patterns and immune development in the offspring. Importantly, Chu et al. demonstrated an association between maternal high-fat diet and distinct changes in the neonatal gut microbiome at birth, which persisted through 4–6 weeks of age (107).
Mother-to-child transmission of obesogenic microbes continues to disrupt microbiome patterns into early childhood. Galley et al. found that the gut microbiomes of toddlers born to obese mothers of high socioeconomic status (SES) clustered away from those of toddlers born from lean high SES mothers (108). In particular, children born to obese mothers had differences in abundances of Faecalibacterium spp., Eubacterium spp., Oscillibacter spp., and Blautia spp., all of which have been correlated to diet and body weight in previous studies.
Interestingly, a recent study published by Mueller et al. reported that maternal obesity-associated differences in the neonatal microbiome are dependent on delivery mode (109). They found that the fecal microbiota of VD infants (n = 18) was disturbed by maternal obesity (n = 5) on day 2 of life. This association was not evident in CSD neonates (n = 56, 26 of which were obese or overweight). While the authors suggest that their results indicate that an altered microbiome is transferred to offspring of obese mothers during vaginal delivery, it is also possible that their results reflect differences in IAP between groups. Importantly, the meconium microbiota at day 2 of life (often the time of the first bowel movement) is likely to reflect the fetal gut contents in utero, which is likely to be influenced by maternal diet and health status. Thus, we would expect to see differences based on maternal pre-pregnancy BMI—regardless of delivery mode. It is possible that antibiotic administration during pregnancy (n = 11 in the CSD group, none reported in the VD group) and delivery (no antibiotic use during delivery reported in the VD group) could mask these differences.
Similarly, Tun et al. found that maternal obesity perturbs the infant microbiome in a delivery mode-dependant manner (68). They reported that VD infants (n = 708) born to overweight or obese mothers had a statistically higher abundance of several genera (e.g., Bacteroides spp., Megasphaera spp., Blautia spp., and Oscillospira spp.) and reduced abundance of others (e.g., Haemophilus and Veillonella), compared to those born from normal weight mothers. Among infants born after emergency CS delivery, Coprococcus spp. and Ruminococcus spp. were more abundant in infants born to overweight or obese mothers than normal weight mothers. Importantly, CS delivery was found to be associated with a twofold increase in risk of obesity in the infant, but this association disappeared after adjustment for co-variables, such as maternal obesity and IAP.
Transmission of aberrant or obesogenic microbiota from obese mothers could potentially explain some of the microbial and metabolic differences reported in infants born by CS vs. those born vaginally. However, this potential mechanism remains unproven, as the ability to induce an obese phenotype via transfer of obesogenic microbiota has only been demonstrated in animal models thus far (102).
Gestational Age at Delivery and Neonatal Intensive Care Unit (NICU) Exposure
Rates of CS delivery increase with decreasing gestational age at delivery (110). Preterm infants differ from their full-term counterparts in terms of their gut microbiota (38, 111–113), immune development (114, 115), and health outcomes (116–118). Arboleya et al. reported that aberrations to the gut microbiota of preterm infants in the first 3 months of life are coupled with a difference in metabolically active short chain fatty acid levels in stool. Although not tested in this particular study, it would be expected that such differences would result in altered immune development among preterm infants.
Preterm infants also experience different nutritional and environmental exposures after birth. The NICU environment is likely to influence the microbiome, so duration of residence and the environmental microbiome of the unit are likely to have a significant impact (119). Infants residing in the NICU also experience differences in nutrition (formula and donor breast milk are common) and antibiotic administration (120). Thus, gestational age and the influence of exposure to the NICU must be accounted for in studies comparing CSD and VD infants.
Inter-Individual Variation
The human microbiome is tremendously variable, both in terms of inter-individual and intra-individual variation (121–126). Thus, any study wishing to define microbial differences in two populations must take into account baseline variability in individual microbiomes, as well as temporal changes within an individual. Studies that compare the microbiomes of infants born by CS or vaginal delivery must have sufficient power to account for variation in the maternal microbiome, as this is likely to exert a large influence on an infant’s microbiome through breastfeeding and physical contact. Large cohorts are thus required with the ability to control variables, such as home environment, presence of pets, and exposures to other microbiome-altering factors including hygiene and maternal/infant diet.
Postnatal Vaginal Seeding
As discussed above, although the data are supportive of a difference in the early-life microbiome of infants born via CS vs. vaginal delivery, the evidence that this is due to the mode of delivery (i.e., differences in exposure to vaginal microbiota during birth) is unconvincing and lacking in critical data. Nevertheless, the perception among the public and medical health professionals alike is that CS delivery deprives the infant of exposure to vaginal microbiota and this leads to neonatal dysbiosis and increased risk of poorer health outcomes. As a consequence, attempts have been made to correct the problem—even though the “problem” may not exist and the benefits of exposure to any individual bacterial species have not been determined.
The widely cited and influential study of Dominguez-Bello and colleagues sought to address the lack of vaginal bacterial exposure in CSD neonates using a practice that they termed “vaginal seeding” (127). Vaginal seeding involves the use of a gauze swab to transfer maternal vaginal fluid, and the microbes contained therein, to a neonate immediately following CS delivery. To test the effectiveness of this procedure, the authors recruited 18 mothers delivering either vaginally (n = 7) or by CS (n = 11). Four of the CSD neonates were exposed to their mothers’ vaginal fluid following birth. The authors reported a partial restoration of the neonatal microbiome (mainly the skin and oral microbiome, less so the gut microbiome) in these four infants after vaginal seeding, with exposed neonates exhibiting microbiomes similar to those of their VD counterparts.
This study had several major weaknesses. Importantly, all mothers delivering by CS received IAP, while only one mother who delivered vaginally was exposed to antibiotics. Additionally, all CS deliveries were elective (no labor), a limitation which the authors themselves acknowledged. It is also important to note that differences in maternal pre-pregnancy BMI and gestational weight gain were not accounted for in this study. The limitation of the small sample size in this study was exacerbated by the fact that there were several missing samples at each time point. Given the high level of baseline inter-individual variation that was evident, the perceived differences in the vaginal fluid exposed group (n = 4) may be purely coincidental and the data are very unconvincing. In fact, swabs of the neonate’s hands immediately following birth revealed that only 3 of the 7 VD neonates had skin microbiomes dominated by Lactobacillus, while 1 of the 2 CSD neonates sampled at birth also had a Lactobacillus-dominated skin microbiome, as did all three of the swabbed neonates sampled at birth. This is in line with previous reports from Martin et al., showing that passage through the vagina rarely transfers Lactobacillus to the infant (47). Remarkably, the primers used in this study were not reported, making it impossible to judge the bacterial coverage of the study.
The premise of this study was based on the assumption that the health consequences and microbial disruptions of CS delivery are due to a lack of exposure to vaginal microbes during delivery. As described in this review, there are a multitude of factors that might contribute to the Cesarean delivery phenotype, and very little evidence to support the theory that exposure to maternal vaginal microbes during delivery is important. Despite the absence of strong supporting evidence for this concept, the notion that replicating the vaginal seeding process will help to mitigate the perceived risks of CS delivery by restoring the natural microbial homeostasis of the infant has gained considerable traction. Alarmingly, the practice of vaginal seeding has become main-stream in some areas, and is often performed without the knowledge or guidance of health care professionals. This practice carries a serious risk of transferring opportunistic pathogens (including viruses and fungi) to newborns which might be asymptomatic in the mother (most notably, GBS) (128). We agree with and support the recent guidelines from the American College of Obstetricians and Gynecologists and the Danish Society of Obstetrics and Gynecology with respect to vaginal seeding in the management of CS delivery (129, 130).
If evidence is eventually provided that vaginal seeding does play a role in the formation of the early-life microbiome, it may be more beneficial to employ the more controllable and pharmacologically safer method of probiotic administration to help promote normal neonatal microbiota. Probiotics are already being trialed to correct dysbiosis preceding NEC in preterm neonates with some success (131, 132), and probiotic formulations of vaginal bacteria are already commercially available. If such an approach is shown to be warranted and potentially beneficial, it could have significant safety and therapeutic advantages over the maternal vaginal seeding procedure trialed by Dominguez-Bello and colleagues.
Conclusion
There is certainly a transient difference in the gut microbiota of infants born by Cesarean delivery compared to their VD counterparts. While this difference appears to be corrected after weaning, it may have lifelong impacts on the development of the immune system. This might underpin the increased incidence of asthma, allergies, and autoimmune diseases seen in CSD infants later in life. However, given the numerous and significant confounding factors present in studies comparing the microbiota after CS and vaginal delivery, it is impossible to say with any certainty that it is the act of delivering vaginally itself which confers this optimal microbiota, or what species/genera of bacteria might be responsible. Differences in antibiotic administration, labor onset, maternal body weight and diet, gestational age, and breastfeeding frequency and duration undoubtedly contribute to differences observed between CSD and VD infants. Further, it is likely that differences between CSD and VD infants do not develop until several days after birth. Given recent evidence that infant microbiome colonization begins in utero, it may be that the importance of “bacterial baptism” of vaginal birth has been significantly over-estimated.
There is a high level of conflicting evidence surrounding this topic. To truly assess the impact of delivery mode on the neonatal microbiome, large scale studies are needed in which mothers delivering by CS are paired with BMI-matched vaginally delivering controls who also receive the same intrapartum antibiotics and who follow similar breastfeeding patterns, combined with strain-specific high-resolution microbiome studies to confirm microbial sources of origin. Although numerous studies have demonstrated an association between CS delivery and altered microbiome establishment, no studies have confirmed causality; the substantial differences in the methodology that exists between studies, including lack of appropriate controls and species-level resolution, further confounds our ability to define this apparent association. Health practitioners should not bow to popular pressure to perform vaginal seeding in the absence of data on need, effectiveness, and appropriate protocols for ensuring safety.
Author Contributions
LS researched and wrote the manuscript. MP and JK contributed to discussion and idea development and critically edited the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding
LS is supported by an Australian Postgraduate Award from the University of Western Australia and an additional scholarship from the Women and Infants Research Foundation of Western Australia. MP and JK are supported by National Health and Medical Research Council Project Grants.
Abbreviations
CSD, cesarean section delivered; DNA, deoxyribonucleic acid; GBS, group B Streptococcus; IAP, intrapartum antibiotic prophylaxis; MRSA, methicillin-resistant Staphylococcus aureus; NEC, necrotizing enterocolitis; NICU, neonatal intensive care unit; OECD, organization for economic co-operation and development; PCR, polymerase chain reaction; qPCR, qualitative polymerase chain reaction; RNA, ribonucleic acid; rRNA, ribosomal ribonucleic acid; RT-qPCR, real-time qualitative polymerase chain reaction; SES, socioeconomic status; VD, vaginally delivered.
References
1. Mueller NT, Bakacs E, Combellick J, Grigoryan Z, Dominguez-Bello MG. The infant microbiome development: mom matters. Trends Mol Med (2015) 21(2):109–17. doi:10.1016/j.molmed.2014.12.002
2. Centers for Disease Control and Prevention (CDC). Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns – Chicago and Los Angeles County, 2004. MMWR Morb Mortal Wkly Rep (2006) 55(12):329–32. doi:10.1097/01.inf.0000226977.41367.58
3. Hällström M, Eerola E, Vuento R, Janas M, Tammela O. Effects of mode of delivery and necrotising enterocolitis on the intestinal microflora in preterm infants. Eur J Clin Microbiol Infect Dis (2004) 23(6):463–70. doi:10.1007/s10096-004-1146-0
4. Debley JS, Smith JM, Redding GJ, Critchlow CW. Childhood asthma hospitalization risk after cesarean delivery in former term and premature infants. Ann Allergy Asthma Immunol (2005) 94(2):228–33. doi:10.1016/S1081-1206(10)61300-2
5. Sevelsted A, Stokholm J, Bønnelykke K, Bisgaard H. Cesarean section and chronic immune disorders. Pediatrics (2015) 135(1):e92–8. doi:10.1542/peds.2014-0596
6. Thavagnanam S, Fleming J, Bromley A, Shields MD, Cardwell CR. A meta-analysis of the association between caesarean section and childhood asthma. Clin Exp Allergy (2008) 38(4):629–33. doi:10.1111/j.1365-2222.2007.02780.x
7. Laubereau B, Filipiak-Pittroff B, von Berg A, Grübl A, Reinhardt D, Wichmann HE, et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Arch Dis Child (2004) 89(11):993–7. doi:10.1136/adc.2003.043265
8. Negele K, Heinrich J, Borte M, von Berg A, Schaaf B, Lehmann I, et al. Mode of delivery and development of atopic disease during the first 2 years of life. Pediatr Allergy Immunol (2004) 15(1):48–54. doi:10.1046/j.0905-6157.2003.00101.x
9. Bager P, Wohlfahrt J, Westergaard T. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin Exp Allergy (2008) 38(4):634–42. doi:10.1111/j.1365-2222.2008.02939.x
10. Eggesbø M, Botten G, Stigum H, Nafstad P, Magnus P. Is delivery by cesarean section a risk factor for food allergy? J Allergy Clin Immunol (2003) 112(2):420–6. doi:10.1067/mai.2003.1610
11. Darmasseelane K, Hyde MJ, Santhakumaran S, Gale C, Modi N. Mode of delivery and offspring body mass index, overweight and obesity in adult life: a systematic review and meta-analysis. PLoS One (2014) 9(2):e87896. doi:10.1371/journal.pone.0087896
12. Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia (2008) 51(5):726–35. doi:10.1007/s00125-008-0941-z
13. Li Y, Tian Y, Zhu W, Gong J, Gu L, Zhang W, et al. Cesarean delivery and risk of inflammatory bowel disease: a systematic review and meta-analysis. Scand J Gastroenterol (2014) 49(7):834–44. doi:10.3109/00365521.2014.910834
14. Polidano C, Zhu A, Bornstein JC. The relation between cesarean birth and child cognitive development. Sci Rep (2017) 7(1):11483. doi:10.1038/s41598-017-10831-y
15. Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med (2016) 22(7):713–22. doi:10.1038/nm.4142
16. Renz H, Holt PG, Inouye M, Logan AC, Prescott SL, Sly PD. An exposome perspective: early-life events and immune development in a changing world. J Allergy Clin Immunol (2017) 140(1):24–40. doi:10.1016/j.jaci.2017.05.015
17. Rautava S, Walker WA. Commensal bacteria and epithelial cross talk in the developing intestine. Curr Gastroenterol Rep (2007) 9(5):385–92. doi:10.1007/s11894-007-0047-7
18. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, Mason LJ, et al. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat Commun (2015) 6:7320. doi:10.1038/ncomms8320
19. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med (2015) 7(307):307ra152. doi:10.1126/scitranslmed.aab2271
20. Stiemsma LT, Arrieta MC, Dimitriu PA, Cheng J, Thorson L, Lefebvre DL, et al. Shifts in Lachnospira and Clostridium sp. in the 3-month stool microbiome are associated with preschool age asthma. Clin Sci (Lond) (2016) 130(23):2199–207. doi:10.1042/CS20160349
21. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy (2014) 44(6):842–50. doi:10.1111/cea.12253
22. Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy (1999) 29(3):342–6. doi:10.1046/j.1365-2222.1999.00560.x
23. Björkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol (2001) 108(4):516–20. doi:10.1067/mai.2001.118130
24. Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol (2001) 107(1):129–34. doi:10.1067/mai.2001.111237
25. Böttcher MF, Nordin EK, Sandin A, Midtvedt T, Björkstén B. Microflora-associated characteristics in faeces from allergic and nonallergic infants. Clin Exp Allergy (2000) 30(11):1590–6. doi:10.1046/j.1365-2222.2000.00982.x
26. Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis (2012) 18(10):1799–808. doi:10.1002/ibd.22860
27. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 7(6):e39242. doi:10.1371/journal.pone.0039242
28. Ajslev TA, Andersen CS, Gamborg M, Sørensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes (Lond) (2011) 35(4):522–9. doi:10.1038/ijo.2011.27
29. Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 21(6):738–48. doi:10.1038/mp.2016.50
30. Neu J, Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol (2011) 38(2):321–31. doi:10.1016/j.clp.2011.03.008
31. Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, et al. Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life. Front Microbiol (2017) 8:738. doi:10.3389/fmicb.2017.00738
32. Hu J, Nomura Y, Bashir A, Fernandez-Hernandez H, Itzkowitz S, Pei Z, et al. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One (2013) 8(11):e78257. doi:10.1371/journal.pone.0078257
33. Mshvildadze M, Neu J, Shuster J, Theriaque D, Li N, Mai V. Intestinal microbial ecology in premature infants assessed with non-culture-based techniques. J Pediatr (2010) 156(1):20–5. doi:10.1016/j.jpeds.2009.06.063
34. Dong XD, Li XR, Luan JJ, Liu XF, Peng J, Luo YY, et al. Bacterial communities in neonatal feces are similar to mothers’ placentae. Can J Infect Dis Med Microbiol (2015) 26(2):90–4. doi:10.1155/2015/737294
35. Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol (2014) 12:87. doi:10.1186/s12915-014-0087-z
36. Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, et al. Optimizing methods and dodging pitfalls in microbiome research. Microbiome (2017) 5(1):52. doi:10.1186/s40168-017-0267-5
37. Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med (2017) 23(3):314–26. doi:10.1038/nm.4272
38. Ardissone AN, de la Cruz DM, Davis-Richardson AG, Rechcigl KT, Li N, Drew JC, et al. Meconium microbiome analysis identifies bacteria correlated with premature birth. PLoS One (2014) 9(3):e90784. doi:10.1371/journal.pone.0090784
39. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostoc species: six cases and review. Rev Infect Dis (1990) 12(4):602–10. doi:10.1093/clinids/12.4.602
40. Al-Ahmad A, Pelz K, Schirrmeister JF, Hellwig E, Pukall R. Characterization of the first oral Vagococcus isolate from a root-filled tooth with periradicular lesions. Curr Microbiol (2008) 57(3):235–8. doi:10.1007/s00284-008-9182-0
41. Teixeira LM, Carvalho MG, Merquior VL, Steigerwalt AG, Brenner DJ, Facklam RR. Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources. J Clin Microbiol (1997) 35(11):2778–81.
42. Shi YC, Guo H, Chen J, Sun G, Ren RR, Guo MZ, et al. Initial meconium microbiome in Chinese neonates delivered naturally or by cesarean section. Sci Rep (2018) 8(1):3255. doi:10.1038/s41598-018-21657-7
43. Biasucci G, Rubini M, Riboni S, Morelli L, Bessi E, Retetangos C. Mode of delivery affects the bacterial community in the newborn gut. Early Hum Dev (2010) 86(Suppl 1):13–5. doi:10.1016/j.earlhumdev.2010.01.004
44. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A (2010) 107(26):11971–5. doi:10.1073/pnas.1002601107
45. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep (2016) 6:23129. doi:10.1038/srep23129
46. Jiménez E, Marín ML, Martín R, Odriozola JM, Olivares M, Xaus J, et al. Is meconium from healthy newborns actually sterile? Res Microbiol (2008) 159(3):187–93. doi:10.1016/j.resmic.2007.12.007
47. Martín R, Heilig GH, Zoetendal EG, Smidt H, Rodríguez JM. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol (2007) 103(6):2638–44. doi:10.1111/j.1365-2672.2007.03497.x
48. Nagpal R, Tsuji H, Takahashi T, Kawashima K, Nagata S, Nomoto K, et al. Sensitive quantitative analysis of the meconium bacterial microbiota in healthy term infants born vaginally or by cesarean section. Front Microbiol (2016) 7:1997. doi:10.3389/fmicb.2016.01997
49. Sakwinska O, Foata F, Berger B, Brüssow H, Combremont S, Mercenier A, et al. Does the maternal vaginal microbiota play a role in seeding the microbiota of neonatal gut and nose? Benef Microbes (2017) 8(5):763–78. doi:10.3920/BM2017.0064
50. Azad MB, Konya T, Maughan H, Guttman DS, Field CJ, Chari RS, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ (2013) 185(5):385–94. doi:10.1503/cmaj.121189
51. Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe (2015) 17(5):690–703. doi:10.1016/j.chom.2015.04.004
52. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 118(2):511–21. doi:10.1542/peds.2005-2824
53. Fallani M, Amarri S, Uusijarvi A, Adam R, Khanna S, Aguilera M, et al. Determinants of the human infant intestinal microbiota after the introduction of first complementary foods in infant samples from five European centres. Microbiology (2011) 157(Pt 5):1385–92. doi:10.1099/mic.0.042143-0
54. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A (2011) 108(Suppl 1):4578–85. doi:10.1073/pnas.1000081107
55. Rutayisire E, Huang K, Liu Y, Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants’ life: a systematic review. BMC Gastroenterol (2016) 16(1):86. doi:10.1186/s12876-016-0498-0
56. Clarke G, O’Mahony SM, Dinan TG, Cryan JF. Priming for health: gut microbiota acquired in early life regulates physiology, brain and behaviour. Acta Paediatr (2014) 103(8):812–9. doi:10.1111/apa.12674
57. Dinan TG, Cryan JF. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration. J Physiol (2017) 595(2):489–503. doi:10.1113/JP273106
58. Martinez FD. The human microbiome. Early life determinant of health outcomes. Ann Am Thorac Soc (2014) 11(Suppl 1):S7–12. doi:10.1513/AnnalsATS.201306-186MG
59. Wallace JG, Gohir W, Sloboda DM. The impact of early life gut colonization on metabolic and obesogenic outcomes: what have animal models shown us? J Dev Orig Health Dis (2016) 7(1):15–24. doi:10.1017/S2040174415001518
60. Berardi A, Pietrangiolillo Z, Bacchi Reggiani ML, Bianco V, Gallesi D, Rossi K, et al. Are postnatal ampicillin levels actually related to the duration of intrapartum antibiotic prophylaxis prior to delivery? A pharmacokinetic study in 120 neonates. Arch Dis Child Fetal Neonatal Ed (2018) 103(2):F152–6. doi:10.1136/archdischild-2016-312546
61. Dumas AM, Girard R, Ayzac L, Beaumont G, Caillat-Vallet E, Depaix F, et al. Effect of intrapartum antibiotic prophylaxis against group B streptococcal infection on comparisons of rates of endometritis and urinary tract infection in multicenter surveillance. Infect Control Hosp Epidemiol (2008) 29(4):327–32. doi:10.1086/529210
62. Nogacka A, Salazar N, Suárez M, Milani C, Arboleya S, Solís G, et al. Impact of intrapartum antimicrobial prophylaxis upon the intestinal microbiota and the prevalence of antibiotic resistance genes in vaginally delivered full-term neonates. Microbiome (2017) 5(1):93. doi:10.1186/s40168-017-0313-3
63. Azad MB, Konya T, Persaud RR, Guttman DS, Chari RS, Field CJ, et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study. BJOG (2016) 123(6):983–93. doi:10.1111/1471-0528.13601
64. Mazzola G, Murphy K, Ross RP, Di Gioia D, Biavati B, Corvaglia LT, et al. Early gut microbiota perturbations following intrapartum antibiotic prophylaxis to prevent group B streptococcal disease. PLoS One (2016) 11(6):e0157527. doi:10.1371/journal.pone.0157527
65. Aloisio I, Mazzola G, Corvaglia LT, Tonti G, Faldella G, Biavati B, et al. Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains. Appl Microbiol Biotechnol (2014) 98(13):6051–60. doi:10.1007/s00253-014-5712-9
66. Fallani M, Young D, Scott J, Norin E, Amarri S, Adam R, et al. Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr (2010) 51(1):77–84. doi:10.1097/MPG.0b013e3181d1b11e
67. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA, Dempsey EM, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother (2012) 56(11):5811–20. doi:10.1128/AAC.00789-12
68. Tun HM, Bridgman SL, Chari R, Field CJ, Guttman DS, Becker AB, et al. Roles of birth mode and infant gut microbiota in intergenerational transmission of overweight and obesity from mother to offspring. JAMA Pediatr (2018) 172(4):368–77. doi:10.1001/jamapediatrics.2017.5535
69. Seedat F, Stinton C, Patterson J, Geppert J, Tan B, Robinson ER, et al. Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: a systematic review. BMC Pregnancy Childbirth (2017) 17(1):247. doi:10.1186/s12884-017-1432-3
70. Lapin B, Piorkowski J, Ownby D, Freels S, Chavez N, Hernandez E, et al. Relationship between prenatal antibiotic use and asthma in at-risk children. Ann Allergy Asthma Immunol (2015) 114(3):203–7. doi:10.1016/j.anai.2014.11.014
71. Metsälä J, Lundqvist A, Virta LJ, Kaila M, Gissler M, Virtanen SM. Prenatal and post-natal exposure to antibiotics and risk of asthma in childhood. Clin Exp Allergy (2015) 45(1):137–45. doi:10.1111/cea.12356
72. Örtqvist AK, Lundholm C, Kieler H, Ludvigsson JF, Fall T, Ye W, et al. Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis. BMJ (2014) 349:g6979. doi:10.1136/bmj.g6979
73. Stensballe LG, Simonsen J, Jensen SM, Bønnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr (2013) 162(4):832–8.e3. doi:10.1016/j.jpeds.2012.09.049
74. McKeever TM, Lewis SA, Smith C, Hubbard R. The importance of prenatal exposures on the development of allergic disease: a birth cohort study using the West Midlands General Practice Database. Am J Respir Crit Care Med (2002) 166(6):827–32. doi:10.1164/rccm.200202-158OC
75. Wohl DL, Curry WJ, Mauger D, Miller J, Tyrie K. Intrapartum antibiotics and childhood atopic dermatitis. J Am Board Fam Med (2015) 28(1):82–9. doi:10.3122/jabfm.2015.01.140017
76. Mueller NT, Whyatt R, Hoepner L, Oberfield S, Dominguez-Bello MG, Widen EM, et al. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int J Obes (Lond) (2015) 39(4):665–70. doi:10.1038/ijo.2014.180
77. Malamitsi-Puchner A, Protonotariou E, Boutsikou T, Makrakis E, Sarandakou A, Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev (2005) 81(4):387–92. doi:10.1016/j.earlhumdev.2004.10.017
78. Black M, Bhattacharya S, Philip S, Norman JE, McLernon DJ. Planned cesarean delivery at term and adverse outcomes in childhood health. JAMA (2015) 314(21):2271–9. doi:10.1001/jama.2015.16176
79. Mårild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF. Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology (2012) 142(1):39–45.e3. doi:10.1053/j.gastro.2011.09.047
80. O’Neill SM, Curran EA, Dalman C, Kenny LC, Kearney PM, Clarke G, et al. Birth by caesarean section and the risk of adult psychosis: a Population-Based Cohort Study. Schizophr Bull (2016) 42(3):633–41. doi:10.1093/schbul/sbv152
81. Thompson AL, Monteagudo-Mera A, Cadenas MB, Lampl ML, Azcarate-Peril MA. Milk- and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiome. Front Cell Infect Microbiol (2015) 5:3. doi:10.3389/fcimb.2015.00003
82. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr (2000) 30(1):61–7. doi:10.1097/00005176-200001000-00019
83. Martín V, Maldonado-Barragán A, Moles L, Rodriguez-Baños M, Campo RD, Fernández L, et al. Sharing of bacterial strains between breast milk and infant feces. J Hum Lact (2012) 28(1):36–44. doi:10.1177/0890334411424729
84. Rogier EW, Frantz AL, Bruno ME, Wedlund L, Cohen DA, Stromberg AJ, et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci U S A (2014) 111(8):3074–9. doi:10.1073/pnas.1315792111
85. Schwartz S, Friedberg I, Ivanov IV, Davidson LA, Goldsby JS, Dahl DB, et al. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol (2012) 13(4):r32. doi:10.1186/gb-2012-13-4-r32
86. Praveen P, Jordan F, Priami C, Morine MJ. The role of breast-feeding in infant immune system: a systems perspective on the intestinal microbiome. Microbiome (2015) 3:41. doi:10.1186/s40168-015-0104-7
87. Pannaraj PS, Li F, Cerini C, Bender JM, Yang S, Rollie A, et al. Association between breast milk bacterial communities and establishment and development of the infant gut microbiome. JAMA Pediatr (2017) 171(7):647–54. doi:10.1001/jamapediatrics.2017.0378
88. Marcobal A, Sonnenburg JL. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect (2012) 18(Suppl 4):12–5. doi:10.1111/j.1469-0691.2012.03863.x
89. Dewey KG, Nommsen-Rivers LA, Heinig MJ, Cohen RJ. Risk factors for suboptimal infant breastfeeding behavior, delayed onset of lactation, and excess neonatal weight loss. Pediatrics (2003) 112(3 Pt 1):607–19. doi:10.1542/peds.112.3.607
90. Bai DL, Wu KM, Tarrant M. Association between intrapartum interventions and breastfeeding duration. J Midwifery Womens Health (2013) 58(1):25–32. doi:10.1111/j.1542-2011.2012.00254.x
91. Evans KC, Evans RG, Royal R, Esterman AJ, James SL. Effect of caesarean section on breast milk transfer to the normal term newborn over the first week of life. Arch Dis Child Fetal Neonatal Ed (2003) 88(5):F380–2. doi:10.1136/fn.88.5.F380
92. Marchi J, Berg M, Dencker A, Olander EK, Begley C. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews. Obes Rev (2015) 16(8):621–38. doi:10.1111/obr.12288
93. Al-Kubaisy W, Al-Rubaey M, Al-Naggar RA, Karim B, Mohd Noor NA. Maternal obesity and its relation with the cesarean section: a hospital based cross sectional study in Iraq. BMC Pregnancy Childbirth (2014) 14:235. doi:10.1186/1471-2393-14-235
94. Berendzen JA, Howard BC. Association between cesarean delivery rate and body mass index. Tenn Med (2013) 106(1):35–7, 42.
95. Cresswell JA, Campbell OM, De Silva MJ, Slaymaker E, Filippi V. Maternal obesity and caesarean delivery in sub-Saharan Africa. Trop Med Int Health (2016) 21(7):879–85. doi:10.1111/tmi.12713
96. Kyvernitakis I, Köhler C, Schmidt S, Misselwitz B, Großmann J, Hadji P, et al. Impact of maternal body mass index on the cesarean delivery rate in Germany from 1990 to 2012. J Perinat Med (2015) 43(4):449–54. doi:10.1515/jpm-2014-0126
97. Roman H, Goffinet F, Hulsey TF, Newman R, Robillard PY, Hulsey TC. Maternal body mass index at delivery and risk of caesarean due to dystocia in low risk pregnancies. Acta Obstet Gynecol Scand (2008) 87(2):163–70. doi:10.1080/00016340701762975
98. Carpenter JR. Intrapartum management of the obese gravida. Clin Obstet Gynecol (2016) 59(1):172–9. doi:10.1097/GRF.0000000000000174
99. Bervoets L, Van Hoorenbeeck K, Kortleven I, Van Noten C, Hens N, Vael C, et al. Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog (2013) 5(1):10. doi:10.1186/1757-4749-5-10
100. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A (2005) 102(31):11070–5. doi:10.1073/pnas.0504978102
101. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature (2006) 444(7122):1022–3. doi:10.1038/4441022a
102. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 444(7122):1027–31. doi:10.1038/nature05414
103. Collado MC, Isolauri E, Laitinen K, Salminen S. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr (2008) 88(4):894–9. doi:10.1093/ajcn/88.4.894
104. Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr (2010) 104(1):83–92. doi:10.1017/S0007114510000176
105. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr (2012) 96(3):544–51. doi:10.3945/ajcn.112.037382
106. Collado MC, Laitinen K, Salminen S, Isolauri E. Maternal weight and excessive weight gain during pregnancy modify the immunomodulatory potential of breast milk. Pediatr Res (2012) 72(1):77–85. doi:10.1038/pr.2012.42
107. Chu DM, Antony KM, Ma J, Prince AL, Showalter L, Moller M, et al. The early infant gut microbiome varies in association with a maternal high-fat diet. Genome Med (2016) 8(1):77. doi:10.1186/s13073-016-0330-z
108. Galley JD, Bailey M, Kamp Dush C, Schoppe-Sullivan S, Christian LM. Maternal obesity is associated with alterations in the gut microbiome in toddlers. PLoS One (2014) 9(11):e113026. doi:10.1371/journal.pone.0113026
109. Mueller NT, Shin H, Pizoni A, Werlang IC, Matte U, Goldani MZ, et al. Birth mode-dependent association between pre-pregnancy maternal weight status and the neonatal intestinal microbiome. Sci Rep (2016) 6:23133. doi:10.1038/srep23133
110. Delnord M, Blondel B, Drewniak N, Klungsøyr K, Bolumar F, Mohangoo A, et al. Varying gestational age patterns in cesarean delivery: an international comparison. BMC Pregnancy Childbirth (2014) 14:321. doi:10.1186/1471-2393-14-321
111. Arboleya S, Binetti A, Salazar N, Fernández N, Solís G, Hernández-Barranco A, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol (2012) 79(3):763–72. doi:10.1111/j.1574-6941.2011.01261.x
112. Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O’Shea CA, et al. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome (2017) 5(1):4. doi:10.1186/s40168-016-0213-y
113. La Rosa PS, Warner BB, Zhou Y, Weinstock GM, Sodergren E, Hall-Moore CM, et al. Patterned progression of bacterial populations in the premature infant gut. Proc Natl Acad Sci U S A (2014) 111(34):12522–7. doi:10.1073/pnas.1409497111
114. Marchant EA, Kan B, Sharma AA, van Zanten A, Kollmann TR, Brant R, et al. Attenuated innate immune defenses in very premature neonates during the neonatal period. Pediatr Res (2015) 78(5):492–7. doi:10.1038/pr.2015.132
115. Melville JM, Moss TJ. The immune consequences of preterm birth. Front Neurosci (2013) 7:79. doi:10.3389/fnins.2013.00079
116. Institute of Medicine (US) Committee on Understanding Premature Birth and Assuring Healthy Outcomes, Behrman RE, Butler AS, editors. Preterm Birth: Causes, Consequences, and Prevention. The National Academies Collection: Reports funded by National Institutes of Health. Washington, DC: National Academies Press (US) (2007). Available from: https://www.ncbi.nlm.nih.gov/pubmed/20669423
117. Boyle EM, Poulsen G, Field DJ, Kurinczuk JJ, Wolke D, Alfirevic Z, et al. Effects of gestational age at birth on health outcomes at 3 and 5 years of age: population based cohort study. BMJ (2012) 344:e896. doi:10.1136/bmj.e896
118. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med (2008) 359(3):262–73. doi:10.1056/NEJMoa0706475
119. Taft DH, Ambalavanan N, Schibler KR, Yu Z, Newburg DS, Ward DV, et al. Intestinal microbiota of preterm infants differ over time and between hospitals. Microbiome (2014) 2:36. doi:10.1186/2049-2618-2-36
120. Patel K, Konduru K, Patra AK, Chandel DS, Panigrahi P. Trends and determinants of gastric bacterial colonization of preterm neonates in a NICU setting. PLoS One (2015) 10(7):e0114664. doi:10.1371/journal.pone.0114664
121. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 12(5):611–22. doi:10.1016/j.chom.2012.10.012
122. Hall AB, Tolonen AC, Xavier RJ. Human genetic variation and the gut microbiome in disease. Nat Rev Genet (2017) 18(11):690–9. doi:10.1038/nrg.2017.63
123. Hisada T, Endoh K, Kuriki K. Inter- and intra-individual variations in seasonal and daily stabilities of the human gut microbiota in Japanese. Arch Microbiol (2015) 197(7):919–34. doi:10.1007/s00203-015-1125-0
124. Salonen A, Lahti L, Salojärvi J, Holtrop G, Korpela K, Duncan SH, et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J (2014) 8(11):2218–30. doi:10.1038/ismej.2014.63
125. Zhu A, Sunagawa S, Mende DR, Bork P. Inter-individual differences in the gene content of human gut bacterial species. Genome Biol (2015) 16:82. doi:10.1186/s13059-015-0646-9
126. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, et al. Temporal and spatial variation of the human microbiota during pregnancy. Proc Natl Acad Sci U S A (2015) 112(35):11060–5. doi:10.1073/pnas.1502875112
127. Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med (2016) 22(3):250–3. doi:10.1038/nm.4039
128. Cunnington AJ, Sim K, Deierl A, Kroll JS, Brannigan E, Darby J. “Vaginal seeding” of infants born by caesarean section. BMJ (2016) 352:i227. doi:10.1136/bmj.i227
129. Committee on Obstetric Practice. Committee opinion no. 725: vaginal seeding. Obstet Gynecol (2017) 130(5):e274–8. doi:10.1097/AOG.0000000000002402
130. Haahr T, Glavind J, Axelsson P, Bistrup Fischer M, Bjurström J, Andrésdóttir G, et al. Vaginal seeding or vaginal microbial transfer from the mother to the caesarean-born neonate: a commentary regarding clinical management. BJOG (2017) 125(5):533–6. doi:10.1111/1471-0528.14792
131. Olsen R, Greisen G, Schrøder M, Brok J. Prophylactic probiotics for preterm infants: a systematic review and meta-analysis of observational studies. Neonatology (2016) 109(2):105–12. doi:10.1159/000441274
Keywords: cesarean delivery, vaginal delivery, delivery mode, neonatal microbiome, infant microbiome, developmental origins, vaginal seeding
Citation: Stinson LF, Payne MS and Keelan JA (2018) A Critical Review of the Bacterial Baptism Hypothesis and the Impact of Cesarean Delivery on the Infant Microbiome. Front. Med. 5:135. doi: 10.3389/fmed.2018.00135
Received: 15 March 2018; Accepted: 20 April 2018;
Published: 04 May 2018
Edited by:
Sinuhe Hahn, Universität Basel, SwitzerlandReviewed by:
Stefan Gebhardt, Stellenbosch University, South AfricaRalph Kay Heinrich Nanan, University of Sydney, Australia
Copyright: © 2018 Stinson, Payne and Keelan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lisa F. Stinson, bGlzYS5zdGluc29uJiN4MDAwNDA7dXdhLmVkdS5hdQ==